Heterocyclic compounds useful to treat HCV

Details Heterocyclic compounds useful to treat HCV Heterocyclic compounds useful to treat HCV

2007-05-22

2007-05-22

Powers, Fiona T. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S254030, C514S326000, C514S364000, C544S138000, C544S367000, C546S187000, C546S209000, C548S145000

Reexamination Certificate

active

10440349

ABSTRACT:
The present invention relates to substituted diphenyl heterocycle compounds and pharmaceutical compositions thereof that inhibit replication of HCV virus. The present invention also relates to the use of the compounds and/or compositions to inhibit HCV replication and/or proliferation and to treat or prevent HCV infections.

REFERENCES:
patent: 2852503 (1958-09-01), Long
patent: 3189447 (1965-06-01), Neugebauer et al.
patent: 3257203 (1966-06-01), Sus
patent: 3335149 (1967-08-01), Preston
patent: 3910942 (1975-10-01), Narayanan et al.
patent: 3964896 (1976-06-01), Brouwer et al.
patent: 4087409 (1978-05-01), Preston
patent: 4405793 (1983-09-01), Fuchs et al.
patent: 4743521 (1988-05-01), Hoffmann et al.
patent: 4752324 (1988-06-01), Thomas et al.
patent: 4777258 (1988-10-01), Sitzmann
patent: 5151441 (1992-09-01), Mueller et al.
patent: 5256666 (1993-10-01), Mueller et al.
patent: 5463071 (1995-10-01), Himmelsbach et al.
patent: 5814627 (1998-09-01), Schwab et al.
patent: 6355669 (2002-03-01), Yamauchi et al.
patent: 6759538 (2002-11-01), Singh et al.
patent: 2002/0035156 (2002-03-01), Roniker et al.
patent: 2002/0049213 (2002-04-01), Weidner-Wells et al.
patent: 392520 (1965-10-01), None
patent: 559 195 (1972-07-01), None
patent: 2137719 (1971-07-01), None
patent: 27 21 955 (1977-05-01), None
patent: 100 32 874 (2002-01-01), None
patent: 563686 (1993-03-01), None
patent: 0 776 894 (1997-06-01), None
patent: 92/7992 (1999-07-01), None
patent: 1 .459.375 (1965-10-01), None
patent: 02-146048 (1990-06-01), None
patent: 03-122652 (1991-05-01), None
patent: 04124178 (1992-04-01), None
patent: WO 93/17671 (1993-09-01), None
patent: WO 94/17059 (1994-06-01), None
patent: WO 95/24397 (1995-09-01), None
patent: WO 98/17652 (1998-04-01), None
patent: WO 98/47509 (1998-10-01), None
patent: WO 99/04390 (1999-01-01), None
patent: WO 99/20309 (1999-04-01), None
patent: WO 02/20436 (2000-03-01), None
patent: WO 00/40242 (2000-07-01), None
patent: WO 00/45799 (2000-08-01), None
patent: WO 00/78726 (2000-12-01), None
patent: WO 02/055025 (2002-07-01), None
patent: WO 03/040112 (2003-05-01), None
patent: WO 2004/018463 (2004-03-01), None
patent: WO 04/099164 (2004-11-01), None
patent: WO 04/103366 (2004-12-01), None
Roth et al., “Zur Kondensation von Chalkonoxyden mit Hydroxylamin”,Arch. Pharm., vol. 94, pp. 769-774, 1961.
Samula, “Oksymowanic Azachalkonow”,Roczniki Chemll, Ann. Soc. Chim. Polonorum, vol. 45, pp. 2063, 1971.
Samula, “Cyclization of Azachalcones and β-Hydroxyketones Oximes”,Roczniki Chemll, Ann soc. Chim, Polonorum, vol. 48, pp. 959-964, 1974.
Howe, et al., “Nitrile Oxide Cycloaddition Routes to 2-(Isoxazoly)-benzoates and 2-(1,2,4-Oxadiazol-3-yl)benzoates”,Heterocycl. Chem., vol. 19, No. 4, pp. 721-726, 1982.
Belgodere et al., “Studies on Isomeric Pyridylisoxazoles”,Heterocycles, vol. 20, No. 3, pp. 501-504, 1983.
Batori et al., “Photoinduced Ring Transformation of Pyrido[1,2-b]pyridazinium-4-olate”,Tetrehedron, vol. 50, No. 16, pp. 4699-4708, 1994.
Kanbara et al., “Preparation of Soluble and Fluorescent Poly(arylene)s by 1,3-Dipolar Polycycloaddition and Properties of the Polymers”,Polymer Bulletin, vol. 36, pp. 673-679, 1996.
Ku et al., “Use of Iodoacetylene as a Dipolarphile in the Synthesis of 5-Iodoisoxazole Derivatives”,Organic Letters, vol. 3, No. 26, pp. 4185-4187, 2001.
Maybridge, plc, Trevillett, Tintagel, Catalogue No. RF01972, Cornwall PL34 OHW, England.
Maybridge, plc, Trevillett, Tintagel, Catalog No. RF01996, Cornwall PL34 OHW, England.
Gatta et al, “Synthesis of [1,2,4]Triazoloquinazoline and [1,2,4]Triazolo-1,4-benzodiazepine derivatives”,J. Heterocyclic. Chem., vol. 30, pp. 11-16, 1993.
Database Chemcats Online! 1999m XP-002310049, Databased accession No. RN 247059-16-1.
Maybridge Hts, Order No. BTB 09742; RN 247059-16-1 Maybridge PLC, Trevillett, Tintagel, Cornwall, PL340HW, UK, Jan. 8, 2004 XP002297442.
STN File CA, Abstract 135:46129 & V.M. Barot et al, Asian Journal of Chemistry (2001), 13(1), pp. 341-343.
STN File CA, Abstract 132:265141 & S.V. Damie et al, Indian Journal of Heterocyclic Chemistry (1999), 9(2), pp. 81-86.
STN File CA, Abstract 132:180505 & V.R. Naik et al, Asian Journal of Chemistry (2000), 12(1), pp. 305-307.
STN File CA, Abstract 129:216539 & S.M. Naik et al, Oriental Journal of Chemistry (1998), 14(1), pp. 167-168.
STN File CA, Abstract 126:74789 & M. Shah et al, Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1996), 35B(12), pp. 1282-1286.
STN File CA, Abstract 122:81186 & S.R. Modi et al, Oriental Journal of Chemistry (1994), 10(1), pp. 85-86.
STN File CA, Abstract 118:191597 & T. Bandiera et al, Journal of Heterocyclic Chemistry (1992), 29(6), pp. 1423-1428.
U.S. Appl. No. 10/838,133, filed May 3, 2004, Singh et al.
U.S. Appl. No. 10/873,914, filed Jun. 22, 2004, Singh et al.

Affiliated with

Also associated with

Rating

Heterocyclic compounds useful to treat HCV does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic compounds useful to treat HCV, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds useful to treat HCV will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3824714